Treatment of children with attention-deficit/hyperactivity disorder: Evaluating a switch from conventional methylphenidate to the once-daily OROS formulation of methylphenidate

被引：0
|
作者：
Santosh, P [1 ]
机构：
[1] Maudsley Hosp & Inst Psychiat, Inst Psychiat, London SE5 8AZ, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)92359-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S451 / S452
页数：2
相关论文
共 50 条
  • [31] Academic, Behavioral, and Cognitive Effects of OROS® Methylphenidate on Older Children with Attention-Deficit/Hyperactivity Disorder
    Wigal, Sharon B.
    Wigal, Tim
    Schuck, Sabrina
    Brams, Matthew
    Williamson, David
    Armstrong, Robert B.
    Starr, H. Lynn
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (02) : 121 - 131
  • [32] Efficiency and tolerability of OROS-methylphenidate in Turkish children and adolescents with attention-deficit/hyperactivity disorder
    Oc, Ozlem Yildiz
    Agaoglu, Belma
    Karakaya, Isik
    Sismanlar, Sahika G.
    Memik, Nursu Cakin
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2010, 11 (01): : 44 - 50
  • [33] Neurofeedback Treatment for Attention-Deficit/Hyperactivity Disorder in Children: A Comparison with Methylphenidate
    Thomas Fuchs
    Niels Birbaumer
    Werner Lutzenberger
    John H. Gruzelier
    Jochen Kaiser
    Applied Psychophysiology and Biofeedback, 2003, 28 : 1 - 12
  • [34] Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder
    Marcus, SC
    Wan, GJ
    Kemner, JE
    Olfson, M
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2005, 159 (06): : 572 - 578
  • [35] Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder
    Weiss, Margaret
    Hechtman, Lily
    Turgay, Atilla
    Jain, Umesh
    Quinn, Declan
    Ahmed, Tahira S.
    Yates, Timothy
    Reiz, Joseph L.
    Donnelly, Graeme A. E.
    Harsanyi, Zoltan
    Darke, Andrew C.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (05) : 675 - 688
  • [36] Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: A comparison with methylphenidate
    Fuchs, T
    Birbaumer, N
    Lutzenberger, W
    Gruzelier, JH
    Kaiser, J
    APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 2003, 28 (01) : 1 - 12
  • [37] Methylphenidate in the treatment of children and adolescents with bipolar disorder and Attention-Deficit/Hyperactivity disorder
    Findling, Robert L.
    Short, Elizabeth J.
    McNamara, Nora K.
    Demeter, Christine A.
    Stansbrey, Robert J.
    Gracious, Barbara L.
    Whipkey, Resaca
    Manos, Michael J.
    Calabrese, Joseph R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (11): : 1445 - 1453
  • [38] Once-Daily Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
    Ayesha S. Lall
    Robert Averbuch
    Current Psychiatry Reports, 2010, 12 : 363 - 365
  • [39] Once-Daily Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
    Lall, Ayesha S.
    Averbuch, Robert
    CURRENT PSYCHIATRY REPORTS, 2010, 12 (05) : 363 - 365
  • [40] Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation
    Yorbik, Ozgur
    Mutlu, Caner
    Ozilhan, Selma
    Eryilmaz, Gul
    Isiten, Nuket
    Alparslan, Serdar
    Saglam, Esra
    THERAPEUTIC DRUG MONITORING, 2015, 37 (03) : 347 - 352
12345